SFINX

Welcome to the Brand page for “SFINX”, which is offered here for Pharmaceutical drug development and services featuring identifying pharmaceutically acceptable excipient mixtures for delivery of poorly water soluble drugs in acceptably sized liquid or semi-solid dosage forms;.

Its status is currently believed to be active. Its class is unavailable. “SFINX” is believed to be currently owned by “TransForm Pharmaceuticals, Inc.”


Owner:
TRANSFORM PHARMACEUTICALS, INC.
Owner Details
Description:
Pharmaceutical drug development and services featuring identifying pharmaceutically acceptable excipient mixtures for delivery of poorly water soluble drugs in acceptably sized liquid or semi-solid dosage forms;
Categories: PHARMACEUTICAL DRUG DEVELOPMENT SERVICES